CURE^® Speaking Out

As part of its Speaking Out video series, CURE spoke with Sarah Miretti Cassidy, director of external affairs at Cancer Hope Network.

As part of its Speaking Out video series, CURE spoke with experts on treatment planning and decision-making in metastatic breast cancer.

As part of its Speaking Out video series, CURE spoke with Throwing Bones founder, Kenny Caps about patient-physician communication, treating myeloma as a chronic condition and how to raise more awareness around the disease.

As part of its Speaking Out video series, on behalf of the Canadian MPN Research Foundation, CURE spoke with two experts on the long-term care of myeloproliferative neoplasms.

In this Speaking Out video series, CURE speaks to the Go2 Foundation for Lung Cancer.

As part of its Speaking Out video series, CURE discusses NCCN guidelines for the treatment of metastatic triple-negative breast cancer, as well as resourves available for patients.

As part of its “Speaking Out” video series, CURE spoke with Stacy Lloyd, board member of the VHL Alliance, about the disease, its treatments and its impact on family discussions around the hereditary cancer.

In this Speaking Out video series, CURE spoke with members of TigerLily Foundation about current challenges in breast cancer care, including disparities, and resources patients have available to them.

As part of its Speaking Out video series, CURE discusses myeloproliferative neoplasms, from symptom management to disease progression and treatment.

On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.

Doctors Yanghee Woo and Sam Klempner react to the rise in the prevalence of gastric cancer in a younger population of patients and emphasize the need for increased funding and research efforts.

In this edition of the Speaking Out video series, on behalf of the Head and Neck Cancer Alliance,CURE spoke with Dr. Michael Moore, from Indiana University School of Medicine about the basics of head and neck cancer.

CURE spoke with the LUNGevity Foundation about lung cancer and its treatments, as well as aspects to cancer outside of day-to-day care.

CURE spoke with Dr. Ogori Kalu, on behalf of the Triple-Negative Breast Cancer Foundation, about the psychosocial effects from a diagnosis, as well as treatment and its side effects.

On behalf of the National Pancreas Foundation, CURE spoke with Dr. Michael Goggin, from Johns Hopkins Medicine, and Tom Birsic, an executive board member since the organization’s inception, about living with pancreatic cancer.

On behalf of the Cutaneous Lymphoma Foundation, CURE spoke with Drs. Steven M. Horwitz and Lauren Pinter-Brown about the basics of cutaneous T-cell lymphoma, as well as current treatment options and those being evaluated for the rare disease.

CURE spoke with representatives of the National Pancreas Foundation on treatment options and outcomes for pancreatic cancer.

On behalf of the American Lung Association, CURE spoke with two health care professionals about lung cancer screening, disparities in care and why clinical trials are important to consider.

On behalf of METAvivor, CURE spoke with Jamil Rivers and Kate Watson about metastatic breast cancer – from its treatment to how it affects individuals and their families.

CURE spoke with representatives of the National Pancreas Foundation on the basics of pancreatic cancer - from early screening to genomic and non-genomic risk factors.

CURE spoke with two physicians, on behalf of the Hairy Cell Leukemia Foundation, about the basics of the disease, as well as its diagnosis and treatment, and also about how patients can learn more about clinical trials.

On behalf of ZERO - The End of Prostate Cancer, CURE spoke with Dr. Charles Ryan about prostate cancer – including the basics, genetics of the disease, developments in advanced prostate cancer and racial disparities.

On behalf of the Multiple Myeloma Research Foundation, CURE spoke with five specialists to offer various resources for patients with multiple myeloma.

CURE speaks with Dr. Susan O'Brien, on behalf of the Leukemia and Lymphoma Society.